Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 15, 2016

View Archived Issues

Mayo Clinic investigates stem cell coated fistula plug in cryptoglandular perianal fistulas

Bayer initiates phase I of BAY-1862864 in relapsed or refractory CD22-positive NHL

First-in-human trial investigates GSK-3008348 for idiopathic pulmonary fibrosis

Roche starts phase I trial of anti-HBV candidate RO-7020322

Adimab announces updates on recent partnerships and development milestones

New collaboration agreements in oncology

NeuroVive enters into a strategic research partnership with University of Pennsylvania

Moderna Therapeutics outlines pipeline progress and goals for the year ahead

Kowa plans cardiovascular outcomes trial of K-877

NIH funds 24 research projects to develop non-traditional therapeutics for bacterial infections

ONO submits a manufacturing and marketing approval application for ONO-5163 in Japan

FDA issues complete response letter for BioMarin's Kyndrisa

Sanofi Pasteur will provide key funding and support to the Human Vaccines Project

Bionaturis to take part in two initiatives

New York Genome Center to investigate genetic basis of autism

BMPR1B-Fc chimera shows bone-increasing effects without toxicity

ALK reports results from trial examining Grazax in the prevention of asthma in children

Boehringer Ingelheim discloses Mdm2-p53 interaction inhibitors

Esteve announces sigma1-receptor ligands

University of Texas System patents agents for African trypanosomiasis

UNAM discloses antidepressants from Casimiroa pubescens

Katholieke Universiteit Leuven and UCB present PI4KIII-beta inhibitors

Bayer Schering Pharma announces BUB1 inhibitors

Intellia launches eXtellia to develop ex vivo gene therapies using CRISPR/Cas9 technology

Implantable synthetic converter cells, a promising strategy to treat psoriasis

PET tracer [18F]RO-6958948 shows promise to assess tau pathology in AD

Inhibition of MyD88 signaling might prevent colitis-associated colorectal cancer

FDA grants orphan drug designation to gene therapy for critical limb ischemia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...